TITLE

'Salvage' Is Key for Thousands

PUB. DATE
July 2006
SOURCE
Guide;Jul2006, Vol. 26 Issue 7, p99
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports that salvage therapy is the last hope for HIV patients, whose drug regimens no longer work, in the U.S. Some physicians are trying to gain access to experimental medications while others put their patient back to previous drugs. Physician Steven Deeks stated that most patients have already developed high-level resistance when protease inhibitors were introduced.
ACCESSION #
21544031

 

Related Articles

  • Health Economics in HIV Disease: A Review of the European Literature. Youle, M.; Trueman, P.; Simpson, K. // PharmacoEconomics;1999 Supplement 1, Vol. 15 Issue 5, p1 

    The costs of providing healthcare resources for patients with HIV disease have continued to rise during the last 2 decades since the first outbreak of AIDS. Although new and effective therapies have become available during this time, and are increasingly being used, outcome measures for, and the...

  • Effect of Maintaining Highly Active Antiretroviral Therapy on AIDS Events among Patients with Late-Stage HIV Infection and Inadequate Response to Therapy. Gandhi, Tejal; Wei Wei; Amin, Kamal; Kazanjian, Powel // Clinical Infectious Diseases;3/15/2006, Vol. 42 Issue 6, p878 

    Background. We evaluated the effect of maintaining highly active antiretroviral therapy (HAART) on the development of new acquired immunodeficiency syndrome (AIDS)-related events in patients with late-stage human immunodeficiency virus (HIV) infection who had suboptimal CD4+ cell count and viral...

  • Accrued HIV evidence turns treatment dogma on its head. Check, Erika // Nature;8/21/2003, Vol. 424 Issue 6951, p866 

    Focuses on the possible health risk posed by HIV drugs in patients. Inefficacy of drugs in subduing virus in HIV positive patients; Comments of various researchers on HIV therapy; Thoughts over the distribution of drugs among various developing countries.

  • A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies. Hahn, K.; Arendt, G.; Braun, J. S.; von Giesen, H.-J.; Husstedt, I. W.; Maschke, M.; Straube, E.; Schielke, E. // Journal of Neurology;Oct2004, Vol. 251 Issue 10, p1260 

    Background Painful HIV-associated sensory neuropathies (HIV-SN) are a common complication of HIV infection. The pathogenesis is unknown and the treatment very limited. Gabapentin (GBP) is effective in painful diabetic neuropathy and postherpetic neuralgia and its effectiveness on painful HIV-SN...

  • The Importance of Potency and Durability in HIV Patient Antiretroviral Therapy Preferences: A Telephone Survey. Sherer Jr., Renslow D.; Fath, Michael J.; Da Silva, Barbara A.; Nicolau, Ana-Maria; Miller, Nancy L. // AIDS Patient Care & STDs;Dec2005, Vol. 19 Issue 12, p794 

    Patients who were receiving or had received antiretroviral therapy (ART) participated in 45-minute telephone interviews to evaluate the importance of major treatment attributes. A Likert scale was used to quantify and rate the importance of 9 ART attributes. Trade-off exercises allowed...

  • HIV Treatment Adherence and Sexual Functioning. Miguez-Burbano, Maria Jose; Espinoza, Luis; Lewis, John E. // AIDS & Behavior;Jan2008, Vol. 12 Issue 1, p78 

    To our knowledge, no studies have considered the bidirectional relationship between HIV infected patients’ social/sexual lives and HAART adherence. To determine it’s potential impact the study sample consisted of 135 men starting HAART and being followed for 6 months. Twenty...

  • Living With HIV.  // Scholastic Choices (Teacher's Edition);May2003, Vol. 18 Issue 8, pT2 

    Profiles Alora Gale, a teenager who was diagnosed to be HIV-positive.

  • Does testing come at the expense of prevention?  // Advocate;5/27/2003, Issue 890, p18 

    Since the early days of the AIDS epidemic, HIV testing has been a critical way to encourage people at high risk to determine their status. But some AIDS activists fear a momentum for wide-spread testing could be coming at the expense of even more critical prevention measures. Citing an increase...

  • Efavirenz.  // Reactions Weekly;4/1/2006, Issue 1095, p11 

    Presents a case report involving the use of efavirenz in an HIV-positive patient. Reference to a study conducted by B. J. Healy and A. R. Freedman published in the March 2006 issue of "HIV Medicine"; Exacerbation of neutropenia during treatment with an efavirenz-containing regimen; Comments of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics